TITLE

Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon γ signalling pathway

AUTHOR(S)
Hsuan-Hao Huang
PUB. DATE
January 2011
SOURCE
Gut;Jan2011, Vol. 60 Issue 1, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: High viraemia of hepatitis B virus (HBV) influences all phases in the development of hepatocellular carcinoma (HCC). This study was designed to estimate the overall contribution of host genetics to HBV viraemia, and investigate the influence of common single-nucleotide polymorphisms (SNPs) in the interferon γ (IFNγ) signalling pathway, which is pivotal in the non-cytolytic clearance of HBV. METHODS: We first determined familial correlations and heritability (ie, proportion of phenotypic variation that is attributable to additive genetic factors) for HBV viraemia using 280 HCC families, including 766 adult HBV carriers. Then family-based association analysis was conducted for viraemia with a panel of 40 SNPs across ten IFNγ-related genes. For replication, seven tagging SNPs in identified candidate regions were also tested in a further 1011 unrelated individuals with longitudinal data on HBV viraemia over 16 years. RESULTS: After adjustment for HBV genotype and sex, significant correlations for viraemia were detected among both siblings and mother–child pairs. Heritability accounted for approximately 30% (p<0.0002) of the variance of viral load, whereas HBV genotype and sex together explained less than 3%. Heritability estimates increased up to 74.0% after further exclusion of subjects with episodes of liver biochemical abnormalities. Our initial family-based association analysis identified two SNPs (rs2284553 (intronic SNP) and rs9808753 (Q64R)) on the IFNγ receptor 2 (IFNGR2) gene that were robustly associated with viraemia after multitest correction (all p<0.02). The SNPs were also associated with the longitudinal levels of viraemia and the persistence of a high viraemia of ≥4.39 log copies/ml (all p<0.0001) in unrelated individuals. CONCLUSIONS: HBV viraemia appears to have substantial heritability. Polymorphisms in the IFNGR2 gene appear to be associated with the variability of viraemia.
ACCESSION #
56482140

 

Related Articles

  • Association between IL28B Polymorphisms and Spontaneous Clearance of Hepatitis B Virus Infection. Kim, Seung Up; Song, Ki Jun; Chang, Hye Young; Shin, Eui-Cheol; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background/Aims: Single-nucleotide polymorphisms (SNPs) near the interleukin 28B gene (IL28B; interferon [IFN]-λ-3) are associated with outcomes of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection treated with peginterferon (PEG-IFN) alpha-based antiviral therapy. In this...

  • 799. Expressed Long Hairpin RNA Sequences Inhibit HBV Replication In Vivo without Inducing an Interferon Response. Ely, Abdullah; Carmona, Sergio; Crowther, Carol; Mufamadi, Steven; Barichievy, Samantha; Weinberg, Marc; Arbuthnot, Patrick // Molecular Therapy;Jun2006, Vol. 13, pS309 

    Chronic infection with the hepatitis B virus (HBV) occurs in approximately 6% of the global population and HBV carriers are at an increased risk for cirrhosis and hepatocellular carcinoma. Licensed therapies against HBV are only partially effective and development of improved treatment...

  • 799. Expressed Long Hairpin RNA Sequences Inhibit HBV Replication In Vivo without Inducing an Interferon Response. Ely, Abdullah; Carmona, Sergio; Crowther, Carol; Mufamadi, Steven; Barichievy, Samantha; Weinberg, Marc; Arbuthnot, Patrick // Molecular Therapy;Jun2006, Vol. 13, pS309 

    Chronic infection with the hepatitis B virus (HBV) occurs in approximately 6% of the global population and HBV carriers are at an increased risk for cirrhosis and hepatocellular carcinoma. Licensed therapies against HBV are only partially effective and development of improved treatment...

  • Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Sung, Wing-Kin; Zheng, Hancheng; Li, Shuyu; Chen, Ronghua; Liu, Xiao; Li, Yingrui; Lee, Nikki P; Lee, Wah H; Ariyaratne, Pramila N; Tennakoon, Chandana; Mulawadi, Fabianus H; Wong, Kwong F; Liu, Angela M; Poon, Ronnie T; Fan, Sheung Tat; Chan, Kwong L; Gong, Zhuolin; Hu, Yujie; Lin, Zhao; Wang, Guan // Nature Genetics;Jul2012, Vol. 44 Issue 7, p765 

    To survey hepatitis B virus (HBV) integration in liver cancer genomes, we conducted massively parallel sequencing of 81 HBV-positive and 7 HBV-negative hepatocellular carcinomas (HCCs) and adjacent normal tissues. We found that HBV integration is observed more frequently in the tumors (86.4%)...

  • Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population. Li Liu; Yao Liu; Jibin Liu; Xiangjun Zhai; Juan Wen; Kaipeng Xie; Hongbing Shen; Zhibin Hu; Zhining Fan // Journal of Biomedical Research;May2013, Vol. 27 Issue 3, p215 

    Recent studies showed that pseudogenes can regulate the expression of their coding gene partners by competing for miRNAs. The E2F family plays a crucial role in the control of cell cycle checkpoint. E2F3P1 is a pseudogene of E2F3. Few studies focused on genetic variations on pseudogenes. In this...

  • Simultaneous Detection of Precore/Basal Core Promoter Mutations in Hepatitis B Virus Using Arrayed Primer Extension. Wai-Yan Ha; Chi-Chiu Lau; Yue, Patrick Y. K.; Hung, Kaman K. M.; Chan, Kelvin; Siu-Hon Chui; Chui, Albert K. K.; Wing-Cheong Yam; Wong, Ricky N. S. // Molecular Diagnosis & Therapy;Mar2006, Vol. 10 Issue 2, p125 

    Background: Hepatitis B is a major disease that causes serious public health problems worldwide. The loss of HBeAg expression due to point mutations or single nucleotide polymorphisms (SNPs) in the precore/basal core promoter region of the hepatitis B virus (HBV) is associated with...

  • Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Li, Meng; Zhao, Hong; Zhang, Xiaosong; Wood, Laura D.; Anders, Robert A.; Choti, Michael A.; Pawlik, Timothy M.; Daniel, Hubert D.; Kannangai, Rajesh; Offerhaus, G Johan A.; Velculescu, Victor E.; Wang, Linfang; Zhou, Shibin; Vogelstein, Bert; Hruban, Ralph H; Papadopoulos, Nick; Cai, Jianqiang; Torbenson, Michael S.; Kinzler, Kenneth W. // Nature Genetics;Sep2011, Vol. 43 Issue 9, p828 

    Through exomic sequencing of ten hepatitis C virus (HCV)-associated hepatocellular carcinomas (HCC) and subsequent evaluation of additional affected individuals, we discovered novel inactivating mutations of ARID2 in four major subtypes of HCC (HCV-associated HCC, hepatitis B virus...

  • Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma. Li, Cong; Bi, Xinyu; Huang, Ying; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Zhang, Meng; Huang, Zhen; Zhao, Hong; Cai, Jianqiang // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Recent genome-wide association studies (GWAS) have identified several common susceptibility loci associated with the risk of hepatocellular carcinoma (HCC) or chronic hepatitis B infection (CHB). However, the relationship between these genetic variants and survival of patients with hepatitis B...

  • Preliminary report on safety and response rate of pegylated interferon- alpha 2a (pegasys) in genotype D chronic hepatitis B patients in Iran. Alavi-Moghaddam, Mostafa; Alavian, Seyed-Moayed; Hajibeigi, Bashir // Gastroenterology & Hepatology from Bed to Bench;Apr2010, Vol. 3 Issue 2, p98 

    Aim: The aim of study was to determine the preliminary result of treatment with pegasys in Iranian chronic hepatitis B patients (with genotype D) referred to Tehran Hepatitis center (THC). Background: The genotype of HBV and ethnicity of the patients can affect the response rate to pegasys....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics